Page 3 - Best Nasopharyngeal cancer doctors: TOP 58 doctors

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Trained in radiation oncology at Marmara University, specializing in precise cancer treatment techniques.

• Specialization in radiation oncology completed in 2016
• Medical degree from Marmara University Faculty of Medicine
• Practices at Emsey Hospital

Associate Professor Dr. Emrah Eraslan specializes in medical oncology with a focus on various cancers, including nasopharyngeal cancer, at Koru Ankara Hospital.

• Over 21 years of experience of experience in internal medicine and medical oncology
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Published multiple papers contributing to oncology research
• Specializes in breast, prostate, lung, and colorectal cancers

Dr. Sridhar specializes in radiotherapy for nasopharyngeal cancer with extensive training and professional memberships.

• Board-certified in radiotherapy with over 30 years of experience of experience
• Member of the Society for Neuro-Oncology and Bangalore Oncology Group
• Trained at Banaras Hindu University and National Board Of Examination
• Active in the Indian Association of Hyperthermia Oncology

Dr. Chaitainya Borde has performed over 30,000 PET scans and treated 1,000+ thyroid cancer patients at HCG Manavata Cancer Centre.

• 11 years of experience of nuclear medicine experience
• Expertise in PET-CT scans and radioiodine therapies
• Published research in medical journals
• Specializes in nuclear cardiology services

Dr. Shruti Kate specializes in advanced cancers, with expertise in immunotherapy and metronomic therapy. She trained at Tata Memorial Hospital, a leading cancer center.

• Experienced in treating lung, breast, and genitourinary cancers
• Member of ASCO, ESMO, and other prestigious oncology societies
• Presented research at the World Conference on Lung Cancer
• Received a travel award for her contributions to oncology

Dr. Shaunak presented groundbreaking research on Stomach Cancer at the American Society of Clinical Oncology Symposium in San Francisco.

• Trained in Medical Oncology at Indraprastha Apollo Hospital, New Delhi
• Specializes in targeted therapies based on molecular cancer research
• Delivered lectures at International Winter School of Oncology at AIIMS
• Experienced Registrar in Medical Oncology at Jawaharlal Nehru Cancer Hospital

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries over 30 years of experience, specializing in Breast and Thoracic Surgical Oncology at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Involved in 200+ clinical trials, including phase 1-3 studies
• Professor for DNB Superspecialty Surgical Oncology and Breast Surgery
• Focuses on improving patients' quality of life post-treatment